申请人:Wang Tao
公开号:US20120093766A1
公开(公告)日:2012-04-19
The disclosure provides compounds of formula I, including pharmaceutically acceptable salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
本公开提供公式I的化合物,包括药学上可接受的盐,以及使用该化合物的组合物和方法。该化合物对丙型肝炎病毒(HCV)具有活性,并可用于治疗感染HCV的患者。